Loading…

Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity

Cancer and malaria are both global health threats. Due to the increase in the resistance to the known drugs, research on new active substances is a priority. Here, we present the design, synthesis, and evaluation of the biological activity of harmicens, hybrids composed of covalently bound harmine/β...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2022-08, Vol.23 (16), p.9315
Main Authors: Poje, Goran, Marinović, Marina, Pavić, Kristina, Mioč, Marija, Kralj, Marijeta, de Carvalho, Lais Pessanha, Held, Jana, Perković, Ivana, Rajić, Zrinka
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3
cites cdi_FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3
container_end_page
container_issue 16
container_start_page 9315
container_title International journal of molecular sciences
container_volume 23
creator Poje, Goran
Marinović, Marina
Pavić, Kristina
Mioč, Marija
Kralj, Marijeta
de Carvalho, Lais Pessanha
Held, Jana
Perković, Ivana
Rajić, Zrinka
description Cancer and malaria are both global health threats. Due to the increase in the resistance to the known drugs, research on new active substances is a priority. Here, we present the design, synthesis, and evaluation of the biological activity of harmicens, hybrids composed of covalently bound harmine/β-carboline and ferrocene scaffolds. Structural diversity was achieved by varying the type and length of the linker between the β-carboline ring and ferrocene, as well as its position on the β-carboline ring. Triazole-type harmicens were prepared using Cu(I)-catalyzed azide-alkyne cycloaddition, while the synthesis of amide-type harmicens was carried out by applying a standard coupling reaction. The results of in vitro biological assays showed that the harmicens exerted moderate antiplasmodial activity against the erythrocytic stage of P. falciparum (IC50 in submicromolar and low micromolar range) and significant and selective antiproliferative activity against the MCF-7 and HCT116 cell lines (IC50 in the single-digit micromolar range, SI > 5.9). Cell localization experiments showed different localizations of nonselective harmicene 36 and HCT116-selective compound 28, which clearly entered the nucleus. A cell cycle analysis revealed that selective harmicene 28 had already induced G1 cell cycle arrest after 24 h, followed by G2/M arrest with a concomitant drastic reduction in the percentage of cells in the S phase, whereas the effect of nonselective compound 36 on the cell cycle was much less pronounced, which agreed with their different localizations within the cell.
doi_str_mv 10.3390/ijms23169315
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9408872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2706243533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3</originalsourceid><addsrcrecordid>eNpdkTtPwzAUhS0EolDYmFEkFoYW_IoTMyCVQilSBQMwMFmO47SukrjYaaX-e9wHVWG6R_d-OrpHB4ALBG8I4fDWTCuPCWKcoPgAnCCKcRdClhzu6RY49X4KISY45segRRhEQcET8DWUrjJK174TvdqFLqP1otaRrPNooJ2z4aij4TJzJvd30aP2Zlx3ovdl3UyC9mvwwdjSjo2SZdRTjVmYZnkGjgpZen2-nW3wOXj66A-7o7fnl35v1FUU4aaLlEoKSCHDENGYSsVprJDOYM6ZZDjBGKVMIZZLTnXKM5nyOClSSiUtWJFlpA3uN76zeVbpPHzbOFmKmTOVdEthpRF_L7WZiLFdCE5hmiY4GFxvDZz9nmvfiMp4pctS1trOvcAJTBjkBNOAXv1Dp3bu6hBvRbFAxIQEqrOhlLPeO13snkFQrDoT-50F_HI_wA7-LYn8AI3ikg8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706243533</pqid></control><display><type>article</type><title>Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Poje, Goran ; Marinović, Marina ; Pavić, Kristina ; Mioč, Marija ; Kralj, Marijeta ; de Carvalho, Lais Pessanha ; Held, Jana ; Perković, Ivana ; Rajić, Zrinka</creator><creatorcontrib>Poje, Goran ; Marinović, Marina ; Pavić, Kristina ; Mioč, Marija ; Kralj, Marijeta ; de Carvalho, Lais Pessanha ; Held, Jana ; Perković, Ivana ; Rajić, Zrinka</creatorcontrib><description>Cancer and malaria are both global health threats. Due to the increase in the resistance to the known drugs, research on new active substances is a priority. Here, we present the design, synthesis, and evaluation of the biological activity of harmicens, hybrids composed of covalently bound harmine/β-carboline and ferrocene scaffolds. Structural diversity was achieved by varying the type and length of the linker between the β-carboline ring and ferrocene, as well as its position on the β-carboline ring. Triazole-type harmicens were prepared using Cu(I)-catalyzed azide-alkyne cycloaddition, while the synthesis of amide-type harmicens was carried out by applying a standard coupling reaction. The results of in vitro biological assays showed that the harmicens exerted moderate antiplasmodial activity against the erythrocytic stage of P. falciparum (IC50 in submicromolar and low micromolar range) and significant and selective antiproliferative activity against the MCF-7 and HCT116 cell lines (IC50 in the single-digit micromolar range, SI &gt; 5.9). Cell localization experiments showed different localizations of nonselective harmicene 36 and HCT116-selective compound 28, which clearly entered the nucleus. A cell cycle analysis revealed that selective harmicene 28 had already induced G1 cell cycle arrest after 24 h, followed by G2/M arrest with a concomitant drastic reduction in the percentage of cells in the S phase, whereas the effect of nonselective compound 36 on the cell cycle was much less pronounced, which agreed with their different localizations within the cell.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23169315</identifier><identifier>PMID: 36012590</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Alkynes ; Antineoplastic Agents - chemistry ; Antiprotozoal agents ; Apoptosis ; Azide ; Biological activity ; Cancer therapies ; Carbolines - pharmacology ; Cell cycle ; Cell Line, Tumor ; Cell Proliferation ; Cycloaddition ; Drug resistance ; Drug Screening Assays, Antitumor ; G2 Phase Cell Cycle Checkpoints ; Harmine ; Humans ; Hybrids ; Localization ; Malaria ; Malaria, Falciparum ; Metallocenes - pharmacology ; Public health ; Reagents ; S phase ; Structure-Activity Relationship</subject><ispartof>International journal of molecular sciences, 2022-08, Vol.23 (16), p.9315</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3</citedby><cites>FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3</cites><orcidid>0000-0002-8523-6340 ; 0000-0003-1223-1116 ; 0000-0002-7970-1429 ; 0000-0002-7165-2722</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2706243533/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2706243533?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,25740,27911,27912,36999,37000,44577,53778,53780,74881</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36012590$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Poje, Goran</creatorcontrib><creatorcontrib>Marinović, Marina</creatorcontrib><creatorcontrib>Pavić, Kristina</creatorcontrib><creatorcontrib>Mioč, Marija</creatorcontrib><creatorcontrib>Kralj, Marijeta</creatorcontrib><creatorcontrib>de Carvalho, Lais Pessanha</creatorcontrib><creatorcontrib>Held, Jana</creatorcontrib><creatorcontrib>Perković, Ivana</creatorcontrib><creatorcontrib>Rajić, Zrinka</creatorcontrib><title>Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Cancer and malaria are both global health threats. Due to the increase in the resistance to the known drugs, research on new active substances is a priority. Here, we present the design, synthesis, and evaluation of the biological activity of harmicens, hybrids composed of covalently bound harmine/β-carboline and ferrocene scaffolds. Structural diversity was achieved by varying the type and length of the linker between the β-carboline ring and ferrocene, as well as its position on the β-carboline ring. Triazole-type harmicens were prepared using Cu(I)-catalyzed azide-alkyne cycloaddition, while the synthesis of amide-type harmicens was carried out by applying a standard coupling reaction. The results of in vitro biological assays showed that the harmicens exerted moderate antiplasmodial activity against the erythrocytic stage of P. falciparum (IC50 in submicromolar and low micromolar range) and significant and selective antiproliferative activity against the MCF-7 and HCT116 cell lines (IC50 in the single-digit micromolar range, SI &gt; 5.9). Cell localization experiments showed different localizations of nonselective harmicene 36 and HCT116-selective compound 28, which clearly entered the nucleus. A cell cycle analysis revealed that selective harmicene 28 had already induced G1 cell cycle arrest after 24 h, followed by G2/M arrest with a concomitant drastic reduction in the percentage of cells in the S phase, whereas the effect of nonselective compound 36 on the cell cycle was much less pronounced, which agreed with their different localizations within the cell.</description><subject>Alkynes</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antiprotozoal agents</subject><subject>Apoptosis</subject><subject>Azide</subject><subject>Biological activity</subject><subject>Cancer therapies</subject><subject>Carbolines - pharmacology</subject><subject>Cell cycle</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cycloaddition</subject><subject>Drug resistance</subject><subject>Drug Screening Assays, Antitumor</subject><subject>G2 Phase Cell Cycle Checkpoints</subject><subject>Harmine</subject><subject>Humans</subject><subject>Hybrids</subject><subject>Localization</subject><subject>Malaria</subject><subject>Malaria, Falciparum</subject><subject>Metallocenes - pharmacology</subject><subject>Public health</subject><subject>Reagents</subject><subject>S phase</subject><subject>Structure-Activity Relationship</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkTtPwzAUhS0EolDYmFEkFoYW_IoTMyCVQilSBQMwMFmO47SukrjYaaX-e9wHVWG6R_d-OrpHB4ALBG8I4fDWTCuPCWKcoPgAnCCKcRdClhzu6RY49X4KISY45segRRhEQcET8DWUrjJK174TvdqFLqP1otaRrPNooJ2z4aij4TJzJvd30aP2Zlx3ovdl3UyC9mvwwdjSjo2SZdRTjVmYZnkGjgpZen2-nW3wOXj66A-7o7fnl35v1FUU4aaLlEoKSCHDENGYSsVprJDOYM6ZZDjBGKVMIZZLTnXKM5nyOClSSiUtWJFlpA3uN76zeVbpPHzbOFmKmTOVdEthpRF_L7WZiLFdCE5hmiY4GFxvDZz9nmvfiMp4pctS1trOvcAJTBjkBNOAXv1Dp3bu6hBvRbFAxIQEqrOhlLPeO13snkFQrDoT-50F_HI_wA7-LYn8AI3ikg8</recordid><startdate>20220818</startdate><enddate>20220818</enddate><creator>Poje, Goran</creator><creator>Marinović, Marina</creator><creator>Pavić, Kristina</creator><creator>Mioč, Marija</creator><creator>Kralj, Marijeta</creator><creator>de Carvalho, Lais Pessanha</creator><creator>Held, Jana</creator><creator>Perković, Ivana</creator><creator>Rajić, Zrinka</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8523-6340</orcidid><orcidid>https://orcid.org/0000-0003-1223-1116</orcidid><orcidid>https://orcid.org/0000-0002-7970-1429</orcidid><orcidid>https://orcid.org/0000-0002-7165-2722</orcidid></search><sort><creationdate>20220818</creationdate><title>Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity</title><author>Poje, Goran ; Marinović, Marina ; Pavić, Kristina ; Mioč, Marija ; Kralj, Marijeta ; de Carvalho, Lais Pessanha ; Held, Jana ; Perković, Ivana ; Rajić, Zrinka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Alkynes</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antiprotozoal agents</topic><topic>Apoptosis</topic><topic>Azide</topic><topic>Biological activity</topic><topic>Cancer therapies</topic><topic>Carbolines - pharmacology</topic><topic>Cell cycle</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cycloaddition</topic><topic>Drug resistance</topic><topic>Drug Screening Assays, Antitumor</topic><topic>G2 Phase Cell Cycle Checkpoints</topic><topic>Harmine</topic><topic>Humans</topic><topic>Hybrids</topic><topic>Localization</topic><topic>Malaria</topic><topic>Malaria, Falciparum</topic><topic>Metallocenes - pharmacology</topic><topic>Public health</topic><topic>Reagents</topic><topic>S phase</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poje, Goran</creatorcontrib><creatorcontrib>Marinović, Marina</creatorcontrib><creatorcontrib>Pavić, Kristina</creatorcontrib><creatorcontrib>Mioč, Marija</creatorcontrib><creatorcontrib>Kralj, Marijeta</creatorcontrib><creatorcontrib>de Carvalho, Lais Pessanha</creatorcontrib><creatorcontrib>Held, Jana</creatorcontrib><creatorcontrib>Perković, Ivana</creatorcontrib><creatorcontrib>Rajić, Zrinka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poje, Goran</au><au>Marinović, Marina</au><au>Pavić, Kristina</au><au>Mioč, Marija</au><au>Kralj, Marijeta</au><au>de Carvalho, Lais Pessanha</au><au>Held, Jana</au><au>Perković, Ivana</au><au>Rajić, Zrinka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-08-18</date><risdate>2022</risdate><volume>23</volume><issue>16</issue><spage>9315</spage><pages>9315-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Cancer and malaria are both global health threats. Due to the increase in the resistance to the known drugs, research on new active substances is a priority. Here, we present the design, synthesis, and evaluation of the biological activity of harmicens, hybrids composed of covalently bound harmine/β-carboline and ferrocene scaffolds. Structural diversity was achieved by varying the type and length of the linker between the β-carboline ring and ferrocene, as well as its position on the β-carboline ring. Triazole-type harmicens were prepared using Cu(I)-catalyzed azide-alkyne cycloaddition, while the synthesis of amide-type harmicens was carried out by applying a standard coupling reaction. The results of in vitro biological assays showed that the harmicens exerted moderate antiplasmodial activity against the erythrocytic stage of P. falciparum (IC50 in submicromolar and low micromolar range) and significant and selective antiproliferative activity against the MCF-7 and HCT116 cell lines (IC50 in the single-digit micromolar range, SI &gt; 5.9). Cell localization experiments showed different localizations of nonselective harmicene 36 and HCT116-selective compound 28, which clearly entered the nucleus. A cell cycle analysis revealed that selective harmicene 28 had already induced G1 cell cycle arrest after 24 h, followed by G2/M arrest with a concomitant drastic reduction in the percentage of cells in the S phase, whereas the effect of nonselective compound 36 on the cell cycle was much less pronounced, which agreed with their different localizations within the cell.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36012590</pmid><doi>10.3390/ijms23169315</doi><orcidid>https://orcid.org/0000-0002-8523-6340</orcidid><orcidid>https://orcid.org/0000-0003-1223-1116</orcidid><orcidid>https://orcid.org/0000-0002-7970-1429</orcidid><orcidid>https://orcid.org/0000-0002-7165-2722</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-08, Vol.23 (16), p.9315
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9408872
source Publicly Available Content Database; PubMed Central
subjects Alkynes
Antineoplastic Agents - chemistry
Antiprotozoal agents
Apoptosis
Azide
Biological activity
Cancer therapies
Carbolines - pharmacology
Cell cycle
Cell Line, Tumor
Cell Proliferation
Cycloaddition
Drug resistance
Drug Screening Assays, Antitumor
G2 Phase Cell Cycle Checkpoints
Harmine
Humans
Hybrids
Localization
Malaria
Malaria, Falciparum
Metallocenes - pharmacology
Public health
Reagents
S phase
Structure-Activity Relationship
title Harmicens, Novel Harmine and Ferrocene Hybrids: Design, Synthesis and Biological Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T18%3A46%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Harmicens,%20Novel%20Harmine%20and%20Ferrocene%20Hybrids:%20Design,%20Synthesis%20and%20Biological%20Activity&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Poje,%20Goran&rft.date=2022-08-18&rft.volume=23&rft.issue=16&rft.spage=9315&rft.pages=9315-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23169315&rft_dat=%3Cproquest_pubme%3E2706243533%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-1cc7f0406201454ac945c1eb0d96a62722186c16da94e89ba8957f844a4f6fbb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2706243533&rft_id=info:pmid/36012590&rfr_iscdi=true